Simulect 20 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung
7680695420012
CH-69542
Pulver
Associated product:
SIMULECT subst seche 20 mg 1 pce
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
basiliximabum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
mannitolum
|
- | Substance | HNIDK |
|
glycinum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
0.955 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69542
- Drug name
- Simulect, Pulver zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- PULVII
- ATC Code
- L04AC02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 26/10/2023
- Authorization expiration date
- 25/10/2028
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SIMULECT subst seche 20 mg 1 pce
- Description (DE)
- SIMULECT Trockensub 20 mg 1 Stk
- Market launch
- 15/03/2024
- Narcotic (BTM)
- No